Daihan Pharmaceutical Co.,Ltd. (KOSDAQ: 023910)

Daihan Pharmaceutical Co.,Ltd. Revenue

Daihan Pharmaceutical Co.,Ltd. had revenue of 48.88B KRW in the quarter ending June 30, 2024, a decrease of -1.58%. This brings the company's revenue in the last twelve months to 198.05B, up 3.01% year-over-year. In the year 2023, Daihan Pharmaceutical Co.,Ltd. had annual revenue of 195.91B with 6.32% growth.

• Revenue (ttm): 198.05B
• Revenue Growth: +3.01%
• P/S Ratio: 0.77
• Revenue / Employee: 358.14M
• Employees: 553
• Market Cap: 152.29B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	195.91B	11.64B	6.32%
Dec 31, 2022	184.27B	12.80B	7.47%
Dec 31, 2021	171.46B	5.38B	3.24%
Dec 31, 2020	166.08B	-2.68B	-1.59%
Dec 31, 2019	168.76B	10.04B	6.33%